ED50 of Dexmedetomidine to Prevent Emergence Agitation in Children

Seoul National University

Status and phase: Unknown; Phase 4

Conditions: Agitation

Treatments: Drug: Dexmedetomidine

Study type: Interventional

Funder types: Other

Identifiers

NCT01374737

KHS_1

Details and patient eligibility

About

There are several recommended doses of dexmedetomidine for prevention of emergence agitation in children. In this study, the investigators examine ED50 in prevention of emergence agitation after tonsillectomy or adenoidectomy in children.

Full description

To investigate ED50, Dixon's up and down method will be used.

Enrollment: 25 estimated patients

Sex: All

Ages: 2 to 12 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• tonsillectomy or adenoidectomy

Exclusion criteria

• recent URI

Trial design

Primary purpose: Prevention

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: Quadruple Blind

---

25 participants in 1 patient group

dexmedetomidine, children

Other group

Treatment:

Drug: Dexmedetomidine